Yarrow Bioscience Inc Stock Analysis & AI Score
Yarrow Bioscience Inc (YARW) has an ST Score of 36.9 (C), driven by its Financial Strength (A+) and held back by its Forecast (D). Analysts rate it Buy with a $5.75 price target (-69.1% downside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
AI Daily Briefing
Analysis by AIYARW Stock Price History
YARW Technical Indicators
FMPEarnings Surprises
Analyst Forecast
Revenue Mix
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Analyst Price Target
ESG Score
YARW Latest Stock News
ST Score
Yarrow Bioscience Inc (YARW) has an ST Score of 36.9 (C), driven by its Financial Strength (A+) and held back by its Forecast (D). Analysts rate it Buy with a $5.75 price target (-69.1% downside).
- Strongest
- Financial StrengthA+
- Weakest
- ForecastD
All factor grades
- Financial StrengthA+
- ValuationC+
- GrowthC-
- ProfitabilityD
- MomentumD
- ForecastD
- Piotroski3/9
Press Releases
Company Contact Details
YARW stock: frequently asked questions
What is YARW's ST Score?
Yarrow Bioscience Inc (YARW) has an ST Score of 36.9 (C), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is YARW a buy, hold, or sell?
Analysts rate YARW a Buy, with a price target of $5.75 (-69.1% vs the current price). Our ST Score grades it C (36.9/100). The ST Score is a data-driven signal, not a recommendation.
What are YARW's factor grades?
Valuation C+, Profitability D, Financial Strength A+, Momentum D, Growth C-, Forecast D.
What is YARW's valuation grade?
Yarrow Bioscience Inc (YARW) earns a valuation grade of C+, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is YARW's growth grade?
Yarrow Bioscience Inc (YARW) earns a growth grade of C-, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is YARW's profitability grade?
Yarrow Bioscience Inc (YARW) earns a profitability grade of D, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is YARW's financial strength grade?
Yarrow Bioscience Inc (YARW) earns a financial strength grade of A+, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for YARW?
The average analyst price target for Yarrow Bioscience Inc (YARW) is $5.75 from 1 analysts, which is -69.1% versus the recent price of $18.60.
What is YARW's Piotroski score?
Yarrow Bioscience Inc (YARW) has a Piotroski F-Score of 3 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.